ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Noven Pharmaceuticals, INC.

Official 2024 U.S. DOL Form 5500 summary for Noven Pharmaceuticals, INC. (Noven Pharmaceuticals, INC. 401(k) Plan · EIN 59-2767632 · PN 001): $61.85M net assets, 336 active participants, and $12.79 per $10,000 (12.79 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorNoven Pharmaceuticals, INC.
Filing IdentifierNoven Pharmaceuticals, INC. 401(k) Plan · EIN 59-2767632 · PN 001
Plan Category & State401(k) Defined Contribution (FL)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$61.85M
Active Participants336
Direct Admin Fee Rate$12.79 per $10,000 (12.79 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderNFP Retirement
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI